Previous Article | Next Article 
Journal of Virology, July 2005, p. 8870-8877, Vol. 79, No. 14
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.14.8870-8877.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
A Specific Region of 37 Amino Acid Residues in the SPRY (B30.2) Domain of African Green Monkey TRIM5
Determines Species-Specific Restriction of Simian Immunodeficiency Virus SIVmac Infection
Emi E. Nakayama,1
Hiroyuki Miyoshi,2
Yoshiyuki Nagai,3 and
Tatsuo Shioda1*
Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University, Osaka,1
BioResource Center, RIKEN Tsukuba Institute, Tsukuba,2
Toyama Institute of Health, Toyama, Japan3
Received 2 December 2004/
Accepted 30 March 2005
Human immunodeficiency virus type 1 (HIV-1) efficiently enters cells of Old World monkeys but encounters a block before reverse transcription. This restriction is mediated by a dominant repressive factor. Recently, a member of the tripartite motif (TRIM) family proteins, TRIM5
, was identified as a blocking factor in a rhesus macaque cDNA library. Among Old World monkey cell lines, the African green monkey kidney cell line CV1 is highly resistant to not only HIV-1 but also simian immunodeficiency virus SIVmac infection. We analyzed TRIM5
of CV1 cells and HSC-F cells, a T-cell line from a cynomolgus monkey, and found that both CV1- and HSC-F-TRIM5
s could inhibit CD4-dependent HIV-1 infection, as well as vesicular stomatitis virus glycoprotein-mediated infection. CV1-TRIM5
could also inhibit SIVmac infection, whereas HSC-F-TRIM5
could not. In the SPRY (B30.2) domain of CV1-TRIM5
, there was a 20-amino-acid duplication that was not present in HSC-F-TRIM5
. A chimeric TRIM5
containing 37 amino acid residues from CV1-TRIM5
, which spanned the 20-amino-acid duplication, in the background of HSC-F-TRIM5
fully gained the ability to inhibit SIVmac infection. Conversely, the mutant CV1-TRIM5
lacking the 20-amino-acid duplication completely lost the ability to restrict SIVmac infection. These findings clearly indicated that a specific region of 37 amino acid residues in the SPRY domain of CV1-TRIM5
contained a determinant of species-specific restriction of SIVmac.
* Corresponding author. Mailing address: Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamada-oka, Suita-shi, Osaka 565-0871, Japan. Phone: 81-6-6879-8346. Fax: 81-6-6879-8347. E-mail:
shioda{at}biken.osaka-u.ac.jp.
Journal of Virology, July 2005, p. 8870-8877, Vol. 79, No. 14
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.14.8870-8877.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
McEwan, W. A., Schaller, T., Ylinen, L. M., Hosie, M. J., Towers, G. J., Willett, B. J.
(2009). Truncation of TRIM5 in the Feliformia Explains the Absence of Retroviral Restriction in Cells of the Domestic Cat. J. Virol.
83: 8270-8275
[Abstract]
[Full Text]
-
Sebastian, S., Grutter, C., de Castillia, C. S., Pertel, T., Olivari, S., Grutter, M. G., Luban, J.
(2009). An Invariant Surface Patch on the TRIM5{alpha} PRYSPRY Domain Is Required for Retroviral Restriction but Dispensable for Capsid Binding. J. Virol.
83: 3365-3373
[Abstract]
[Full Text]
-
Cai, C., Masumiya, H., Weisleder, N., Pan, Z., Nishi, M., Komazaki, S., Takeshima, H., Ma, J.
(2009). MG53 Regulates Membrane Budding and Exocytosis in Muscle Cells. J. Biol. Chem.
284: 3314-3322
[Abstract]
[Full Text]
-
Kar, A. K., Diaz-Griffero, F., Li, Y., Li, X., Sodroski, J.
(2008). Biochemical and Biophysical Characterization of a Chimeric TRIM21-TRIM5{alpha} Protein. J. Virol.
82: 11669-11681
[Abstract]
[Full Text]
-
Yap, M. W., Lindemann, D., Stanke, N., Reh, J., Westphal, D., Hanenberg, H., Ohkura, S., Stoye, J. P.
(2008). Restriction of Foamy Viruses by Primate Trim5{alpha}. J. Virol.
82: 5429-5439
[Abstract]
[Full Text]
-
Brennan, G., Kozyrev, Y., Kodama, T., Hu, S.-L.
(2007). Novel TRIM5 Isoforms Expressed by Macaca nemestrina. J. Virol.
81: 12210-12217
[Abstract]
[Full Text]
-
Schaller, T., Hue, S., Towers, G. J.
(2007). An Active TRIM5 Protein in Rabbits Indicates a Common Antiviral Ancestor for Mammalian TRIM5 Proteins. J. Virol.
81: 11713-11721
[Abstract]
[Full Text]
-
Song, H., Nakayama, E. E., Yokoyama, M., Sato, H., Levy, J. A., Shioda, T.
(2007). A Single Amino Acid of the Human Immunodeficiency Virus Type 2 Capsid Affects Its Replication in the Presence of Cynomolgus Monkey and Human TRIM5{alpha}s. J. Virol.
81: 7280-7285
[Abstract]
[Full Text]
-
Luban, J.
(2007). Cyclophilin A, TRIM5, and Resistance to Human Immunodeficiency Virus Type 1 Infection. J. Virol.
81: 1054-1061
[Full Text]
-
Ohkura, S., Yap, M. W., Sheldon, T., Stoye, J. P.
(2006). All Three Variable Regions of the TRIM5{alpha} B30.2 Domain Can Contribute to the Specificity of Retrovirus Restriction.. J. Virol.
80: 8554-8565
[Abstract]
[Full Text]
-
Ylinen, L. M. J., Keckesova, Z., Webb, B. L. J., Gifford, R. J. M., Smith, T. P. L., Towers, G. J.
(2006). Isolation of an Active Lv1 Gene from Cattle Indicates that Tripartite Motif Protein-Mediated Innate Immunity to Retroviral Infection Is Widespread among Mammals.. J. Virol.
80: 7332-7338
[Abstract]
[Full Text]
-
Bishop, K. N., Mortuza, G. B., Howell, S., Yap, M. W., Stoye, J. P., Taylor, I. A.
(2006). Characterization of an amino-terminal dimerization domain from retroviral restriction factor fv1.. J. Virol.
80: 8225-8235
[Abstract]
[Full Text]
-
Si, Z., Vandegraaff, N., O'hUigin, C., Song, B., Yuan, W., Xu, C., Perron, M., Li, X., Marasco, W. A., Engelman, A., Dean, M., Sodroski, J.
(2006). Evolution of a cytoplasmic tripartite motif (TRIM) protein in cows that restricts retroviral infection. Proc. Natl. Acad. Sci. USA
103: 7454-7459
[Abstract]
[Full Text]
-
Keckesova, Z., Ylinen, L. M. J., Towers, G. J.
(2006). Cyclophilin A Renders Human Immunodeficiency Virus Type 1 Sensitive to Old World Monkey but Not Human TRIM5{alpha} Antiviral Activity.. J. Virol.
80: 4683-4690
[Abstract]
[Full Text]
-
Passerini, L. D., Keckesova, Z., Towers, G. J.
(2006). Retroviral Restriction Factors Fv1 and TRIM5{alpha} Act Independently and Can Compete for Incoming Virus before Reverse Transcription. J. Virol.
80: 2100-2105
[Abstract]
[Full Text]
-
Sebastian, S., Sokolskaja, E., Luban, J.
(2006). Arsenic Counteracts Human Immunodeficiency Virus Type 1 Restriction by Various TRIM5 Orthologues in a Cell Type-Dependent Manner. J. Virol.
80: 2051-2054
[Abstract]
[Full Text]